HS

Himanshu Singh

Director Director DIN 07007669
DIN 07007669 First appointment Feb 2015 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Himanshu Singh

Data last updated:

Himanshu Singh was a Director at Alienate Pharmaceutical (India) Private Limited (2017–2018) and Director at Ages Life Science Private Limited (from 2015). The companies operate in Pharma.

DIN 07007669
Primary Designation Director
Industry Pharma
First Appointment 23 Feb 2015
Oldest Company Age 11 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 May 20172017₹2 Lakh (FY 2025)Active
Ages Life Science Private Limited U74120UP2015PTC069125
Director23 Feb 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ages Life Science Private Limited
Alienate Pharmaceutical (India) Private Limited
Premium access

Shareholding and investment profile for Himanshu Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Himanshu Singh

Himanshu Singh was first appointed on 23 Feb 2015 as Director at Ages Life Science Private Limited. The most recent appointment on record is 24 May 2017 at Alienate Pharmaceutical (India) Private Limited.

Himanshu Singh held 2 earlier board appointments: Alienate Pharmaceutical (India) Private Limited (Director, 24 May 2017 to 16 Dec 2018); Ages Life Science Private Limited (Director, from 23 Feb 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available